GEERT CAUWENBERGH Insider Trading
Get free email notifications about insider trading for GEERT CAUWENBERGH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GEERT CAUWENBERGH. GEERT CAUWENBERGH is an Chief Executive Officer in BARRIER THERAPEUTICS INC ($BTRX) and an Chief Executive Officer in Phio Pharmaceuticals Corp. ($RXII) and a Director in Phio Pharmaceuticals Corp. ($PHIO) and a President & CEO in RXi Pharmaceuticals Corp ($RXII).
Address: C/O BARRIER THERAPEUTICS, INC. 600 COLLEGE ROAD EAST, SUITE 3200 PRINCETON 08540 NJ
Companies in which GEERT CAUWENBERGH is an Insider
BARRIER THERAPEUTICS INC
Trading Symbol: BTRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GEERT CAUWENBERGH: Chief Executive Officer
Holdings: 11,000 shares
Latest Transaction: Aug 10 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Phio Pharmaceuticals Corp.
Trading Symbol: PHIOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GEERT CAUWENBERGH: Director, Chief Executive Officer, President & CEO
Holdings: 22,822 shares
Current Value: $14,606
Latest Transaction: Mar 03 2021
$PHIO Market Capitalization: $4.88M
$PHIO Previous Close: $0.64
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of GEERT CAUWENBERGH
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 03 2021 | PHIO | Phio Pharmaceutica ... | CAUWENBERGH GEERT | Director | Grant | A | 0.00 | 10,000 | 0 | 22,822 | 12.8 K to 22.8 K (+77.99 %) |
Nov 20 2019 | PHIO | Phio Pharmaceutica ... | CAUWENBERGH GEERT | Director | Grant | A | 0.10 | 225,000 | 22,500 | 704,841 | 479.8 K to 704.8 K (+46.89 %) |
Aug 02 2019 | PHIO | Phio Pharmaceutica ... | CAUWENBERGH GEERT | Director | Payment of Exercise | F | 0.40 | 1,751 | 706 | 479,841 | 481.6 K to 479.8 K (-0.36 %) |
Mar 01 2019 | RXII | Phio Pharmaceutica ... | CAUWENBERGH GEERT | Chief Executive Off ... | Grant | A | 0.38 | 152,415 | 57,887 | 481,592 | 329.2 K to 481.6 K (+46.30 %) |
Feb 19 2019 | RXII | Phio Pharmaceutica ... | CAUWENBERGH GEERT | Chief Executive Off ... | Grant | A | 0.36 | 22,279 | 8,096 | 329,177 | 306.9 K to 329.2 K (+7.26 %) |
Feb 04 2019 | RXII | Phio Pharmaceutica ... | CAUWENBERGH GEERT | Chief Executive Off ... | Grant | A | 0.38 | 21,470 | 8,096 | 306,898 | 285.4 K to 306.9 K (+7.52 %) |
Jan 22 2019 | RXII | Phio Pharmaceutica ... | CAUWENBERGH GEERT | Chief Executive Off ... | Grant | A | 0.34 | 23,729 | 8,096 | 285,428 | 261.7 K to 285.4 K (+9.07 %) |